BridgeMD
New treatment option for Post Partum Hemorrhage
Official title Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.
ClinicalTrials.gov ID: NCT06604325
What this study is testing
What is Tranexamic acid injection?
Tranexamic acid injection is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for post partum hemorrhage.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Postpartum hemorrhage continues to be the leading cause of maternal morbidity and mortality. Globally, it is responsible for 25% of all pregnancy-related deaths.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- The women undergoing cesarean delivery (both elective and emergency) during the study period.
- Willing to participate in the study after understanding the concept.
You likely can't join if
- Critically ill patient.
- Not willing to give consent to participate in the study
- Cases diagnosed with a ruptured uterus or undergoing caesarian hysterectomy during operation.
The study team makes the final eligibility decision.
Where it's taking place
- Fatehpur, Uttar Pradesh, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fatehpur, Uttar Pradesh, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.